Upregulating β-hexosaminidase activity in rodents prevents α-synuclein lipid associations and protects dopaminergic neurons from α-synuclein-mediated neurotoxicity
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Upregulating β-hexosaminidase activity in rodents prevents α-synuclein lipid associations and protects dopaminergic neurons from α-synuclein-mediated neurotoxicity
Authors
Keywords
-
Journal
Acta Neuropathologica Communications
Volume 8, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-08-06
DOI
10.1186/s40478-020-01004-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lysosomal Glycosphingolipid Storage Diseases
- (2019) Bernadette Breiden et al. Annual Review of Biochemistry
- Lipid and immune abnormalities causing age-dependent neurodegeneration and Parkinson’s disease
- (2019) Penelope J. Hallett et al. Journal of Neuroinflammation
- Lewy pathology in Parkinson’s disease consists of crowded organelles and lipid membranes
- (2019) Sarah H. Shahmoradian et al. NATURE NEUROSCIENCE
- Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease
- (2019) Mylene Huebecker et al. Molecular Neurodegeneration
- Novel Results and Concepts Emerging From Lipid Cell Biology Relevant to Degenerative Brain Aging and Disease
- (2019) Ole Isacson et al. Frontiers in Neurology
- Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies
- (2019) Mike A Nalls et al. LANCET NEUROLOGY
- Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson’s Disease and Dementia with Lewy Bodies
- (2018) Tim E. Moors et al. MOLECULAR NEUROBIOLOGY
- Altered expression of genes involved in ganglioside biosynthesis in substantia nigra neurons in Parkinson’s disease
- (2018) Jay S. Schneider PLoS One
- Ganglioside lipids accelerate α-synuclein amyloid formation
- (2018) Ricardo Gaspar et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Lipid-dependent deposition of alpha-synuclein and Tau on neuronal Secretogranin II-positive vesicular membranes with age
- (2018) Oeystein R. Brekk et al. Scientific Reports
- Lifetime risk of common neurological diseases in the elderly population
- (2018) Silvan Licher et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Stereological Estimation of Dopaminergic Neuron Number in the Mouse Substantia Nigra Using the Optical Fractionator and Standard Microscopy Equipment
- (2017) Chi Wang Ip et al. Jove-Journal of Visualized Experiments
- Parkinson disease
- (2017) Werner Poewe et al. Nature Reviews Disease Primers
- Accumulated α-synuclein affects the progression of GM2 gangliosidoses
- (2016) Kyoko Suzuki et al. EXPERIMENTAL NEUROLOGY
- Lysosomal Storage Diseases: From Pathophysiology to Therapy
- (2015) Giancarlo Parenti et al. Annual Review of Medicine
- Sustained Systemic Glucocerebrosidase Inhibition Induces Brain α-Synuclein Aggregation, Microglia and Complement C1q Activation in Mice
- (2015) Emily M. Rocha et al. ANTIOXIDANTS & REDOX SIGNALING
- Sphingolipid lysosomal storage disorders
- (2014) Frances M. Platt NATURE
- Modelling Ser129 Phosphorylation Inhibits Membrane Binding of Pore-Forming Alpha-Synuclein Oligomers
- (2014) Georg Sebastian Nübling et al. PLoS One
- Boosting chaperone-mediated autophagy in vivo mitigates α-synuclein-induced neurodegeneration
- (2013) Maria Xilouri et al. BRAIN
- Reversibility of neuropathology in Tay–Sachs-related diseases
- (2013) María-Begoña Cachón-González et al. HUMAN MOLECULAR GENETICS
- Gangliosides and Gangliosidoses: Principles of Molecular and Metabolic Pathogenesis
- (2013) K. Sandhoff et al. JOURNAL OF NEUROSCIENCE
- Impairment of neuropsychological behaviors in ganglioside GM3-knockout mice
- (2011) Kimie Niimi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Molecular Basis for the Glycosphingolipid-Binding Specificity of α-Synuclein: Key Role of Tyrosine 39 in Membrane Insertion
- (2011) Jacques Fantini et al. JOURNAL OF MOLECULAR BIOLOGY
- Progressive Neurodegeneration or Endogenous Compensation in an Animal Model of Parkinson's Disease Produced by Decreasing Doses of Alpha-Synuclein
- (2011) James B. Koprich et al. PLoS One
- Design-based Stereology
- (2010) Rogely Waite Boyce et al. TOXICOLOGIC PATHOLOGY
- Dynamic Changes in Presynaptic and Axonal Transport Proteins Combined with Striatal Neuroinflammation Precede Dopaminergic Neuronal Loss in a Rat Model of AAV -Synucleinopathy
- (2009) C. Y. Chung et al. JOURNAL OF NEUROSCIENCE
- Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
- (2009) E. Sidransky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mice lacking ganglioside GM3 synthase exhibit complete hearing loss due to selective degeneration of the organ of Corti
- (2009) M. Yoshikawa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hexosaminidase assays
- (2008) Michaela Wendeler et al. GLYCOCONJUGATE JOURNAL
- Pre-synaptic dopaminergic compensation after moderate nigrostriatal damage in non-human primates
- (2008) Xiomara A. Perez et al. JOURNAL OF NEUROCHEMISTRY
- β-Synuclein occursin vivoin lipid-associated oligomers and forms hetero-oligomers with α-synuclein
- (2008) Eitan Israeli et al. JOURNAL OF NEUROCHEMISTRY
- In vivo gene delivery for development of mammalian models for Parkinson's disease
- (2007) Ayse Ulusoy et al. EXPERIMENTAL NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation